Combined Local Immunotherapy and Radiotherapy in metastatic Melanoma: an interventional single-arm trial.
Phase of Trial: Phase II
Latest Information Update: 09 Sep 2015
At a glance
- Drugs Aldesleukin (Primary) ; Imiquimod (Primary) ; Poly ICLC (Primary)
- Indications Skin cancer
- Focus Therapeutic Use
- Acronyms CLIRM-1
- 31 Dec 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 25 Nov 2009 New trial record